eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
5.11
-0.06 (-1.26%)
At close: Aug 7, 2026, 4:00 PM EDT
5.19
+0.08 (1.67%)
After-hours: Aug 7, 2026, 7:46 PM EDT
eXoZymes Market Cap
eXoZymes has a market cap or net worth of $46.51 million as of August 7, 2026. Its market cap has decreased by -44.47% in one year.
Market Cap
46.51M
Enterprise Value
46.23M
1-Year Change
-44.47%
Ranking
Category
Stock Price
$5.11
ChartMarket Cap Chart
Since November 13, 2024, eXoZymes's market cap has decreased from $70.30M to $46.51M, a decrease of -33.84%. That is a compound annual growth rate of -21.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 46.51M | -49.13% |
| Dec 31, 2025 | 91.42M | -41.85% |
| Dec 31, 2024 | 157.23M | 123.64% |
| Nov 13, 2024 | 70.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veraxa Biotech AG | 50.18M |
| aTyr Pharma | 50.14M |
| Immutep | 49.96M |
| Filana Therapeutics | 48.07M |
| Karyopharm Therapeutics | 48.05M |
| Mereo BioPharma Group | 47.29M |
| Seres Therapeutics | 47.16M |
| Impact BioMedical | 46.91M |